Neurotech, Neuromodulation, Alzheimers.
pharma and the large non-profit organizations aren’t nimble for a variety of reasons — the need for long term research, high barriers to entry, and the need for large potential profits to justify the investments. (My conclusions are based on a market analysis that may be found here. WHAT ABOUT